Impact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases
Crossref DOI link: https://doi.org/10.1186/s12885-016-2095-6
Published Online: 2016-02-10
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Volk, Andreas M.
Fritzmann, Johannes
Reissfelder, Christoph
Weber, Georg F.
Weitz, Jürgen
Rahbari, Nuh N.
License valid from 2016-02-10